SR
Swayampakula Ramakanth HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
156
Avg Return
Past Year
Past Year
7.3%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
94.1%
Neutral
5.9%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Health Information Services
Medical Devices
Medical Distribution
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $2 |
22%
upside
| 4 | +41% |
0
%
| 9 May ‘25 5 months ago |
|
|
|
Buy
Reiterated
| $5 |
229%
upside
| 4 | +70% |
0
%
| 11 Apr ‘25 6 months ago |
|
|
|
Buy
Reiterated
| $3.50 |
46%
upside
| 2 | +34% |
0
%
| 2 Apr ‘25 6 months ago |
|
|
|
Buy
Reiterated
| $19 |
702%
upside
| 1 | +6.8% |
0
%
| 28 Mar ‘25 6 months ago |
|
|
|
Neutral
Reiterated
| – | – | 4 | -34% |
0
%
| 27 Mar ‘25 6 months ago |
|
|
|
Buy
Reiterated
| $7 |
52%
upside
| 6 | +6% |
0
%
| 19 Mar ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $25 |
403%
upside
| 2 | -34% |
0
%
| 13 Mar ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $70 |
161%
upside
| 3 | -21% |
0
%
| 3 Mar ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $60 |
65%
upside
| 3 | -8.2% |
0
%
| 28 Feb ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $33 |
298%
upside
| 5 | -19% |
0
%
| 26 Feb ‘25 7 months ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | – |
–
| 15 Nov ‘24 11 months ago |
|